|
Impurity HA-2
|
雜質(zhì)HA-2
|
13257-67-5
|
|
1-
cyclopropylnap
hthalen-2-
amine
|
1-環(huán)丙基萘-2-胺
|
2385682-46-0
|
|
Impurity HA-1
|
雜質(zhì)HA-1
|
32926-43-5
|
|
Oxytocin solution
|
縮宮素溶液
|
50-56-6
|
|
Amlodipine Desfluoro Impurity
|
氨氯地平去氯雜質(zhì)
|
88150-52-1
|
|
Impurity DA-4
|
雜質(zhì)DA-4
|
1416793-14-0
|
|
Upadacitinib Impurity 03
|
烏帕替尼雜質(zhì)03
|
1708997-42-5
|
|
ethyl 8-(2-hydroxybenzamido)octanoate
|
8-(2-羥基苯甲酰胺)辛酸乙酯
|
1027911-46-1
|
|
Isomer Ⅰ of Lansoprolol Hydrochloride
|
鹽酸蘭地洛爾異構(gòu)體Ⅰ
|
1253907-83-3
|
|
Selexipag Impurity 12
|
司來(lái)帕格雜質(zhì)12
|
475086-28-3
|
|
Piperacillin EP Impurity S
|
哌拉西林EP雜質(zhì)S
|
|
|
Vortioxetine Impurity 20
|
沃替西汀雜質(zhì)20
|
14340-33-1
|
|
Stiripentol Impurity 15
|
司替戊醇雜質(zhì)15
|
631-65-2
|
|
(R) Ethyl 3- (iodomethyl) hexanoate
|
(R)-3-(碘甲基)己酸乙酯
|
2428577-25-5
|
|
Piperacillin EP Impurity M(sodium salt)
|
哌拉西林EP雜質(zhì)M(鈉鹽)
|
|
|
ERYTHROMYCIN IMPURITY A
|
紅霉素雜質(zhì)A
|
82230-93-1
|
|
Hexetidine EP Impurity C
|
海克替啶EP雜質(zhì) C
|
141-94-6
|
|
Piperacillin EP Impurity N
|
哌拉西林EP雜質(zhì)N
|
|
|
Roxadustat Impurity B
|
羅沙司他雜質(zhì)B
|
708263-68-7
|
|
Beninidipine hydrochloride impurity 5
|
鹽酸貝尼地平雜質(zhì)5
|
39562-27-1
|
|
2,6-Dichlorobenzoic acid
|
2，6-二氯苯甲酸
|
50-30-6
|
|
Vortioxetine Impurity 12
|
沃替西汀雜質(zhì)12
|
27080-90-6
|
|
Selexipag Impurity 14
|
司來(lái)帕格雜質(zhì)14
|
2010956-45-1
|
|
Vonoprazan Impurity 60
|
沃諾拉贊雜質(zhì)60
|
2932441-73-9
|
|
Vortioxetine Impurity 15
|
沃替西汀雜質(zhì)15
|
2925447-38-5
|
|
Upadacitinib Impurity 12
|
烏帕替尼雜質(zhì)12
|
51814-19-8
|
|
Stiripentol Impurity A
|
司替戊醇雜質(zhì)A
|
49763-96-4
|
|
Impurity HA-7
|
雜質(zhì)HA-7
|
62-57-7
|
|
Selexipag Impurity 15
|
司來(lái)帕格雜質(zhì)15
|
475085-57-5
|
|
Diepoxy (hydroxyfluorophenyl) epoxide
|
二環(huán)氧(羥基氟苯基)環(huán)氧化物
|
873950-17-5
|
|
Beninidipine hydrochloride impurity B
|
鹽酸貝尼地平雜質(zhì)B
|
118935-44-7
|
|
Nifedipine Impurity E
|
硝苯地平雜質(zhì)E
|
21829-26-5
|
|
Upadacitinib Impurity 04
|
烏帕替尼雜質(zhì)04
|
1708997-43-6
|
|
Beninidipine hydrochloride impurity 4
|
鹽酸貝尼地平雜質(zhì)4
|
101072-61-1
|
|
Upadacitinib Impurity 10
|
烏帕替尼雜質(zhì)10
|
2715120-88-8
|
|
Methyl Myristate
|
肉豆蔻酸甲酯
|
124-10-7
|
|
3,4-Dichlorobenzoic acid
|
3，4-二氯苯甲酸
|
51-44-5
|
|
Vonoprazan Impurity 75
|
沃諾拉贊雜質(zhì)75
|
1224739-02-9
|
|
Etomidate Impurity 16
|
依托咪酯雜質(zhì)16
|
2374709-47-2
|
|
Isomer Ⅱ of Lansoprolol Hydrochloride
|
鹽酸蘭地洛爾異構(gòu)體Ⅱ
|
1253907-85-5
|
|
Selexipag Impurity 16
|
司來(lái)帕格雜質(zhì)16
|
2287345-22-4
|
|
Piperacillin EP Impurity K
|
哌拉西林EP雜質(zhì)K
|
|
|
Ziprasidone EP Impurity D
|
齊拉西酮EP雜質(zhì)D
|
1303996-68-0
|
|
Remdesivir triphosphate
|
瑞德西韋三磷酸
|
1355149-45-9
|
|
Impurity DA-2
|
雜質(zhì)DA-2
|
3082-75-5
|
|
Roxadustat Impurity A
|
羅沙司他雜質(zhì)A
|
2599284-47-4
|
|
Vortioxetine Impurity 16
|
沃替西汀雜質(zhì)16
|
36596-75-5
|
|
Beninidipine hydrochloride impurity 13
|
鹽酸貝尼地平雜質(zhì)13
|
3323-73-7
|
|
Isocyclosporine impurity H
|
異環(huán)孢素雜質(zhì)H
|
83602-43-1
|
|
Upadacitinib Impurity 01
|
烏帕替尼雜質(zhì)01
|
1428243-27-9
|
|
Upadacitinib Impurity 19
|
烏帕替尼雜質(zhì)19
|
1869118-25-1
|
|
4-chlorobenzoic acid
|
對(duì)氯苯甲酸
|
74-11-3
|
|
Impurity DA-8
|
雜質(zhì)DA-8
|
1570206-15-3
|
|
Impurity DA-5
|
雜質(zhì)DA-5
|
538334-18-8
|
|
Deoxyribonucleic acid sodium salt
|
脫氧核糖核酸鈉鹽
|
73049-39-5
|
|
Nifedipine Impurity E
|
硝苯地平雜質(zhì)E
|
39562-75-9
|
|
Nifedipine Impurity 25
|
硝苯地平雜質(zhì)25
|
76258-20-3
|
|
Vortioxetine Impurity 03
|
沃替西汀雜質(zhì)03
|
508234-03-5
|
|
Landiolol Hydrochloride
|
鹽酸蘭地洛爾
|
144481-98-1
|
|
Beninidipine hydrochloride impurity E
|
鹽酸貝尼地平雜質(zhì)E
|
74936-72-4
|
|
Vortioxetine Impurity 13
|
沃替西汀雜質(zhì)13
|
960203-41-2
|
|
Beninidipine hydrochloride impurity 11
|
鹽酸貝尼地平雜質(zhì)11
|
1185304-22-6
|
|
SNAC reference standard
|
SNAC對(duì)照品
|
203787-91-1
|
|
Beninidipine hydrochloride impurity 10
|
鹽酸貝尼地平雜質(zhì)10
|
85387-34-4
|
|
Impurity DA-7
|
雜質(zhì)DA-7
|
850324-83-3
|
|
Isomer Ⅲ of Lansoprolol Hydrochloride
|
鹽酸蘭地洛爾異構(gòu)體Ⅲ
|
1253907-81-1
|
|
Vortioxetine Impurity 06
|
沃替西汀雜質(zhì)06
|
1293342-97-8
|
|
Dicloxacillin Impurity 6
|
雙氯西林雜質(zhì)6
|
1642576-88-2
|
|
2,5-Dichlorobenzoic acid
|
2，5-二氯苯甲酸
|
50-79-3
|
|
Hexetidine EP Impurity B
|
?？颂驵P雜質(zhì) B
|
3687-16-9
|
|
ERYTHROMYCIN IMPURITY I
|
紅霉素雜質(zhì)I
|
546-57-6
|
|
(S)-1-Amino-3-chloro-2-propanol hydrochloride
|
利奈唑胺雜質(zhì)26鹽酸鹽
|
34839-13-9
|
|
Nifedipine Impurity F
|
硝苯地平雜質(zhì)F
|
53055-15-5
|
|
Nicardipine hydrochloride EP impurity B
|
鹽酸尼卡地平EP雜質(zhì)B
|
71784-27-5
|
|
Etomidate Impurity 10
|
依托咪酯雜質(zhì)10
|
66512-37-6
|
|
Kasharin reference substance
|
卡沙侖對(duì)照品
|
2037-95-8
|
|
Piperacillin EP Impurity R
|
哌拉西林EP雜質(zhì)R
|
|
|
ERYTHROMYCIN IMPURITY C
|
紅霉素雜質(zhì)C
|
41451-91-6
|
|
Formoterol EP Impurity G
|
福莫特羅EP雜質(zhì)G
|
23239-32-9
|
|
Vortioxetine Impurity 17
|
沃替西汀雜質(zhì)17
|
1639263-83-4
|
|
Stiripentol Impurity 4
|
司替戊醇雜質(zhì)4
|
106175-03-5
|
|
Upadacitinib Impurity 16
|
烏帕替尼雜質(zhì)16
|
1428243-24-6
|
|
Hyaluronidase; Hyaluronidase
|
透明質(zhì)酸酶;玻璃酸酶
|
9001-54-1
|
|
(3R) -3- ({[(1S) -1-carbamidopropyl] amino} methyl) hexanoate ethyl ester
|
(3R)-3-({[(1S)-1-甲酰胺基
丙基]氨基}甲基)己酸乙酯
|
748760-80-7
|
|
Hexetidine EP Impurity A
|
?？颂驵P雜質(zhì)A
|
188655-38-1
|
|
Bathocuproinedisulfonic acid disodium salt
|
浴銅靈二磺酸 二鈉鹽
|
52698-84-7
|
|
Beninidipine hydrochloride impurity 6
|
鹽酸貝尼地平雜質(zhì)6
|
40641-47-2
|
|
Impurity DA-6
|
雜質(zhì)DA-6
|
123105-87-3
|
|
Piperacillin EP Impurity P
|
哌拉西林EP雜質(zhì)P
|
|
|
Stiripentol Impurity 17
|
司替戊醇雜質(zhì)17
|
58344-73-3
|
|
Impurities HY-VIII in the raw material of ezetimibe
|
依折麥布原料藥雜質(zhì)HY-VIII
|
2743547-96-6
|
|
2-chloro-4-
cyclopropyl-1-
isothiocyanato
naphthalene
|
2-氯-4-環(huán)丙基-1-異硫氰基萘
|
2170177-13-4
|
|
Hydroxyisopropyl epoxide
|
羥基異丙基環(huán)氧化物
|
873950-18-6
|
|
2,4-Dichlorobenzoic acid
|
2，4-二氯苯甲酸
|
50-84-0
|
|
Roxadustat Impurity D
|
羅沙司他雜質(zhì)D
|
1421312-35-7
|
|
Beninidipine hydrochloride impurity D
|
鹽酸貝尼地平雜質(zhì)D
|
91599-78-9
|
|
Nifedipine Impurity D
|
硝苯地平雜質(zhì)D
|
117177-77-2
|
|
Piperacillin EP Impurity L
|
哌拉西林EP雜質(zhì)L
|
|
|
Piperacillin EP Impurity F
|
哌拉西林EP雜質(zhì)F
|
|
|
Vortioxetine Impurity 07
|
沃替西汀雜質(zhì)07
|
2137793-92-9
|